NEW YORK (GenomeWeb) - WuXi NextCode said today that it has closed a $75 million Series B financing in which several of the company's existing investors and partners participated.

Temasek and Yunfeng Capital co-led the financing. Other investors include Amgen Ventures and 3W Partners. Temasek is a Singapore-based investment firm, while Yunfeng is a private equity firm founded by Alibaba Group Holding's Jack Ma.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.